 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Course Overview

What is this course about?

Who is the mini-course for?

Teaching Goals

Class 3 Solvents with Low Toxic Potential

Key Concepts

SLIDE 2 — Concept Simplified (60 sec)

SLIDE 3 — Case Study with Dialogue (90 sec)

SLIDE 4 — Practical Application (60 sec)

10-Point Audit / Inspection Checklist (Class 3 Residual Solvents)

Copy of 10-Point Audit / Inspection Checklist (Class 3 Residual Solvents)

Quiz

Part A — Quiz (5 Scenario-Based Questions)

SLIDE 5 — Knowledge Check + Takeaways (45 sec)

Survey/Feedback

Part B — Reflection

Part C — Top 5 Takeaways

Navigating pharmaceutical regulatory compliance can be complex, especially when it comes to managing residual solvents. Welcome to "Evaluating Class 3 Solvents Under ICH Q3C(R9) Guidelines," a comprehensive mini-course designed to demystify the regulatory requirements surrounding solvents with low toxic potential.

Navigating pharmaceutical regulatory compliance can be complex, especially when it comes to managing residual solvents. Welcome to "Evaluating Class 3 Solvents Under ICH Q3C(R9) Guidelines," a comprehensive mini-course designed to demystify the regulatory requirements surrounding solvents with low toxic potential. Whether you are dealing with drug substances, excipients, or final drug products, understanding the nuances of the ICH Q3C(R9) guidelines is critical for ensuring patient safety and product quality.

This course provides an in-depth look at the criteria that classify a solvent as Class 3 and explains why these solvents require no health-based exposure limit under specific thresholds. You will explore key concepts such as Permitted Daily Exposure (PDE), Option 1 versus Option 2 limits, and the mathematical relationship between 50 mg/day, 5000 ppm, and the 0.5% threshold. Through practical case studies, simulated batch scenarios, and a 10-point audit checklist, you will learn how to implement scientifically justified specifications and robust control strategies.

By the end of this course, you will be equipped to confidently evaluate borderline situations using risk-based judgment, align your processes with USP <467> and Ph. Eur. 2.4.24 standards, and avoid common industry pitfalls. Join us to enhance your regulatory expertise, streamline your manufacturing workflows, and ensure seamless compliance during your next audit or inspection.

128. Evaluating Class 3 Solvents Under ICH Q3C(R9) Guidelines

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>The evaluation and control of residual solvents represent a critical intersection of patient safety, product quality, and regulatory compliance within pharmaceutical manufacturing. Under the ICH Q3C(R9) guidelines, Class 3 solvents are designated as having low toxic potential, meaning they generally do not require a strict health-based exposure limit under standard dosing conditions. However, this permissive classification frequently leads to industry misconceptions, such as the erroneous assumption that these solvents can be entirely excluded from specifications or regulatory scrutiny. For professionals across Quality Assurance, Quality Control, Manufacturing, and Regulatory Affairs, mastering the specific criteria that govern Class 3 solvents is essential. This requires a precise understanding of the mathematical and regulatory relationships between the 50 mg/day threshold, the 5000 ppm limit, and the 0.5% concentration cap to ensure robust compliance with compendial standards, including USP &lt;467&gt; and Ph. Eur. 2.4.24.</p>

<p>This course delivers a structured, progressive workflow designed to equip drug substance, excipient, and drug product operational staff with the practical tools necessary for rigorous solvent management. Participants will navigate critical concepts such as Permitted Daily Exposure (PDE) and the toxicological rationale behind Class 3 categorizations, without requiring a prior background in toxicology. Through detailed case studies and simulated batch scenarios, learners will analyze the compliance risks associated with improper solvent handling and learn to differentiate between scientifically justified control strategies and inadequate documentation practices. By culminating in a comprehensive 10-point audit and inspection checklist, the curriculum ensures that analysts running GC methods, QA personnel approving Certificates of Analysis, and Regulatory Affairs staff defending dossiers can confidently implement control strategies that withstand stringent external audits.</p>
        </div>
    </div>
</div>
